ISDA

Deposition Date 2013-03-19

Release Date 2014-03-05

Last Version Date 2024-03-20

Entry Detail

PDB ID:

4JP4

Keywords:

HYDROLASE

Title:

Mmp13 in complex with a reverse hydroxamate Zn-binder

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.43 Å

R-Value Free:

0.17

R-Value Work:

0.15

R-Value Observed:

0.15

Space Group:

C 1 2 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Collagenase 3
Gene (Uniprot):MMP13
Chain IDs:A, B
Chain Length:173
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:P45452 Pfam ID:PF00413 EC:3.4.24.17

Ligand Molecules

AZ4

Primary Citation

Hydantoin based inhibitors of MMP13--discovery of AZD6605.

De Savi, C, Waterson, D, Pape, A, Lamont, S, Hadley, E, Mills, M, Page, K.M, Bowyer, J, Maciewicz, R.A.Show

Bioorg.Med.Chem.Lett. 23 4705 4712 (2013)

PMID: 23810497 DOI: 10.1016/j.bmcl.2013.05.089

Abstact

Piperidine ether and aryl piperazine hydantoins are reported as potent inhibitors of MMP13. A medicinal chemistry campaign focused on replacing the reverse hydroxamate zinc binding group associated with historical inhibitors with a hydantoin zinc binding group then optimising MMP13 potency, solubility and DMPK properties whilst maintaining good selectivity over MMP14. A number of high quality candidates were progressed and following rat and dog safety evaluation, AZD6605 (3m) was identified as a candidate drug.

Legend

Protein

Chemical

Disease

Primary Citation of related structures